Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
OncoSynergy, Inc.
🇺🇸
United States
Country
🇺🇸
United States
Ownership
Holding
Established
2011-01-01
Employees
1
Market Cap
-
Website
http://www.oncosynergy.com
Clinical Trials
Related News
Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection
Phase 1
Terminated
Conditions
High Grade Glioma
Glioblastoma
Glioblastoma Multiforme
Glioma, Malignant
Anaplastic Astrocytoma
Interventions
Drug: OS2966
Drug: Gadoteridol
Subscribe
First Posted Date
2020-10-29
Last Posted Date
2023-08-18
Lead Sponsor
OncoSynergy, Inc.
Target Recruit Count
7
Registration Number
NCT04608812
Locations
🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy